Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Electrochemotherapy in Breast Cancer: A Review of References</title>
<author><name sortKey="Schmidt, G" sort="Schmidt, G" uniqKey="Schmidt G" first="G." last="Schmidt">G. Schmidt</name>
<affiliation><nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Juhasz Boss, I" sort="Juhasz Boss, I" uniqKey="Juhasz Boss I" first="I." last="Juhasz-Böss">I. Juhasz-Böss</name>
<affiliation><nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Solomayer, E F" sort="Solomayer, E F" uniqKey="Solomayer E" first="E.-F." last="Solomayer">E.-F. Solomayer</name>
<affiliation><nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Herr, D" sort="Herr, D" uniqKey="Herr D" first="D." last="Herr">D. Herr</name>
<affiliation><nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">24976637</idno>
<idno type="pmc">4069212</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069212</idno>
<idno type="RBID">PMC:4069212</idno>
<idno type="doi">10.1055/s-0034-1368538</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000050</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000050</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Electrochemotherapy in Breast Cancer: A Review of References</title>
<author><name sortKey="Schmidt, G" sort="Schmidt, G" uniqKey="Schmidt G" first="G." last="Schmidt">G. Schmidt</name>
<affiliation><nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Juhasz Boss, I" sort="Juhasz Boss, I" uniqKey="Juhasz Boss I" first="I." last="Juhasz-Böss">I. Juhasz-Böss</name>
<affiliation><nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Solomayer, E F" sort="Solomayer, E F" uniqKey="Solomayer E" first="E.-F." last="Solomayer">E.-F. Solomayer</name>
<affiliation><nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Herr, D" sort="Herr, D" uniqKey="Herr D" first="D." last="Herr">D. Herr</name>
<affiliation><nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Geburtshilfe und Frauenheilkunde</title>
<idno type="ISSN">0016-5751</idno>
<idno type="eISSN">1438-8804</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Electrochemotherapy is a new method for the local treatment of cutaneous and subcutaneous
metastases. If surgery and/or radiotherapy are no longer possible, this innovative technology
can be used effectively for local tumour control. The minor side effects of the therapy and the
low intraoperative duration of treatment make it possible to admit patients to hospital for just
a short time. Thus, the repeated use of electrochemotherapy has allowed for an increase in the
rate of complete remissions. In fact, in 2013, this form of treatment, which consists of a
low-dose cytostatic and electroporation, was also included in the mammary guidelines of the
Working Group for Gynaecological Oncology (AGO) and the German Cancer Society (DKG). The
favourable cost-benefit ratio makes this method of treatment very interesting in clinical
practice and, as a result, it is already being used successfully in many German hospitals.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Geburtshilfe Frauenheilkd</journal-id>
<journal-id journal-id-type="iso-abbrev">Geburtshilfe Frauenheilkd</journal-id>
<journal-id journal-id-type="doi">10.1055/s-00000020</journal-id>
<journal-title-group><journal-title>Geburtshilfe und Frauenheilkunde</journal-title>
</journal-title-group>
<issn pub-type="ppub">0016-5751</issn>
<issn pub-type="epub">1438-8804</issn>
<publisher><publisher-name>Georg Thieme Verlag KG</publisher-name>
<publisher-loc>Stuttgart · New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">24976637</article-id>
<article-id pub-id-type="pmc">4069212</article-id>
<article-id pub-id-type="doi">10.1055/s-0034-1368538</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Electrochemotherapy in Breast Cancer: A Review of References</article-title>
<trans-title-group xml:lang="de"><trans-title>Elektrochemotherapie beim Mammakarzinom: eine Literaturübersicht</trans-title>
</trans-title-group>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Schmidt</surname>
<given-names>G.</given-names>
</name>
<xref rid="AF797-1" ref-type="aff"></xref>
<xref rid="CO-1" ref-type="author-notes"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Juhasz-Böss</surname>
<given-names>I.</given-names>
</name>
<xref rid="AF797-1" ref-type="aff"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Solomayer</surname>
<given-names>E.-F.</given-names>
</name>
<xref rid="AF797-1" ref-type="aff"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Herr</surname>
<given-names>D.</given-names>
</name>
<xref rid="AF797-1" ref-type="aff"></xref>
</contrib>
</contrib-group>
<aff id="AF797-1"><institution>Uniklinik Homburg, Homburg</institution>
</aff>
<author-notes><corresp id="CO-1"><bold>Correspondence </bold>
Dr. Gilda Schmidt <institution>Uniklinik Homburg</institution>
<addr-line>Kirrbergerstraße100</addr-line>
<addr-line>66421 Homburg</addr-line>
<email>gilda.schmidt@uks.eu</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub"><month>6</month>
<year>2014</year>
</pub-date>
<volume>74</volume>
<issue>6</issue>
<fpage>557</fpage>
<lpage>562</lpage>
<history><date date-type="received"><day>23</day>
<month>2</month>
<year>2014</year>
</date>
<date date-type="rev-recd"><day>24</day>
<month>3</month>
<year>2014</year>
</date>
<date date-type="accepted"><day>25</day>
<month>4</month>
<year>2014</year>
</date>
</history>
<permissions><copyright-statement>© Thieme Medical Publishers</copyright-statement>
</permissions>
<abstract><p>Electrochemotherapy is a new method for the local treatment of cutaneous and subcutaneous
metastases. If surgery and/or radiotherapy are no longer possible, this innovative technology
can be used effectively for local tumour control. The minor side effects of the therapy and the
low intraoperative duration of treatment make it possible to admit patients to hospital for just
a short time. Thus, the repeated use of electrochemotherapy has allowed for an increase in the
rate of complete remissions. In fact, in 2013, this form of treatment, which consists of a
low-dose cytostatic and electroporation, was also included in the mammary guidelines of the
Working Group for Gynaecological Oncology (AGO) and the German Cancer Society (DKG). The
favourable cost-benefit ratio makes this method of treatment very interesting in clinical
practice and, as a result, it is already being used successfully in many German hospitals.</p>
</abstract>
<trans-abstract xml:lang="de"><sec><title>Zusammenfassung</title>
<p>Die Elektrochemotherapie ist eine neue Methode zur lokalen Behandlung von kutanen und subkutanen
Metastasen. Sind Operation und/oder Radiatio nicht mehr möglich, so kann diese innovative
Technik effektiv zur lokalen Tumorkontrolle eingesetzt werden. Die geringen Nebenwirkungen der
Therapie und die geringe intraoperative Behandlungsdauer machen eine kurze Hospitalisation
möglich. Durch wiederholten Einsatz der Elektrochemotherapie kann dabei die Rate an
Komplettremissionen erhöht werden, sodass 2013 diese aus einem niedrig dosiertem Zytostatikum
und Elektroporation bestehende Therapieform auch in die Mamma-Leitlinien der AGO/DKG aufgenommen
wurde. Die günstige Kosten-Nutzen-Relation macht dieses Behandlungsverfahren in der klinischen
Praxis sehr interessant, sodass es bereits erfolgreich in zahlreichen deutschen Kliniken
eingesetzt wird.</p>
</sec>
</trans-abstract>
<kwd-group xml:lang="en"><title>Key words</title>
<kwd>breast cancer</kwd>
<kwd>metastasis</kwd>
<kwd>mammary</kwd>
</kwd-group>
<kwd-group xml:lang="de"><title>Schlüsselwörter</title>
<kwd>Mammakarzinom</kwd>
<kwd>Metastasierung</kwd>
<kwd>Mamma</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000050 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000050 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Pmc |étape= Corpus |type= RBID |clé= |texte= }}
This area was generated with Dilib version V0.6.31. |